4.6 Article

Plasma ceramides containing saturated fatty acids are associated with risk of type 2 diabetes

Journal

JOURNAL OF LIPID RESEARCH
Volume 62, Issue -, Pages -

Publisher

ELSEVIER
DOI: 10.1016/j.jlr.2021.100119

Keywords

epidemiology; elderly; ceramides; sphingomyelins; diabetes; cohort study; cardiovascular disease; hazard ratios; Cox proportional hazards; saturated fatty acids

Funding

  1. National Heart, Lung, and Blood Institute (NHLBI) [R01 HL128575]
  2. National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK103657, P30-DK035816]
  3. NHLBI [75N92021D00006, HHSN268201200036C, HHSN268200800007C, HHSN268201800001C, N01HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01HC85086, U01HL080295, U01HL130114]
  4. National Institute on Aging [R01AG023629]
  5. National Institute of Neurological Disorders and Stroke

Ask authors/readers for more resources

Recent studies have shown that different types of saturated fatty acids bound to sphingolipids may affect their biological activity. This study investigated the associations of various ceramide and sphingomyelin species with incident type 2 diabetes. The results suggest that higher levels of specific ceramide species (Cer-16, Cer-18, Cer-20, Cer-22) are associated with an increased risk of diabetes.
Recent studies suggest that the type of saturated fatty acid bound to sphingolipids influences the biological activity of those sphingolipids. However, it is unknown whether associations of sphingolipids with diabetes may differ by the identity of bound lipid species. Here, we investigated associations of 15 ceramide (Cer) and SM species (i.e., all sphingolipids, measured with coefficient of variation less than 20%) with incident type 2 diabetes in the Cardiovascular Health Study (n = 3,645), a large cohort study of cardiovascular disease among elderly adults who were followed from 1989 to 2015. Diabetes incidence was defined as fasting glucose >= 126 mg/dl or nonfasting glucose >= 200 mg/dl; reported use of insulin or oral hypoglycemic medication; or documentation of diabetes diagnosis through the Centers for Medicare and Medicaid Services records. Associations of each sphingolipid with incident diabetes were assessed using a Cox proportional hazards regression model. We found that higher circulating levels of Cer with acylated palmitic acid (Cer-16), stearic acid containing Cer (Cer-18), arachidic acid containing Cer (Cer-20), and behenic acid containing Cer (Cer-22) were each associated with a higher risk of diabetes. The hazard ratios for incident diabetes per 1 SD higher log levels of each Cer species were as follows: 1.21 (95% CI: 1.09-1.34) for Cer-16, 1.23 (95% CI: 1.10-1.37) for Cer-18, 1.14 (95% CI: 1.02-1.26) for Cer-20, and 1.18 (95% CI: 1.06-1.32) for Cer-22. In conclusion, higher levels of Cer-16, Cer-18, Cer-20, and Cer-22 were associated with a higher risk of diabetes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available